
Results
3
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
3 companies
Pharma Mar
Market Cap: €1.7b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€98.90
7D
1.6%
1Y
11.5%
Oryzon Genomics
Market Cap: €229.6m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.
ORY
€2.96
7D
7.6%
1Y
6.5%
Adolfo Domínguez
Market Cap: €49.4m
Engages in the design, manufacture, acquisition, sale, marketing, retail, import, and export of ready-made garments, footwear, handbags and accessories, household linen, furniture, and decorative objects.
ADZ
€5.35
7D
-6.1%
1Y
12.4%